| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Rapt Therapeutics, Inc. (RAPT) has 9 insiders with recent SEC Form 4 filings, including 8 buys and 12 sells. RAPT is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 0 | - | - | |
| Dir | 0 | - | - | |
| Other | 0 | - | - | |
| Dir | 0 | - | - | |
| CFO | 0 | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 9, 2021 | Robbins Wendye59 | Director | Buy | 1,400 | $21.07 | $29,504.87 | +4.5% | +60.2% | +12.0% | |
| Apr 1, 2021 | Ho William75 | Chief Medical Officer | Sell | 1,000 | $22.66 | $22,660.00 | -1.5% | +38.2% | -0.7% | |
| Mar 15, 2021 | Ho William75 | Chief Medical Officer | Sell | 1,000 | $21.91 | $21,910.00 | -1.5% | +76.2% | -6.2% | |
| Mar 1, 2021 | Ho William75 | Chief Medical Officer | Sell | 1,000 | $18.60 | $18,600.00 | -1.5% | - | - | |
| Feb 16, 2021 | Ho William75 | Chief Medical Officer | Sell | 1,000 | $21.81 | $21,810.00 | -1.5% | - | - | |
| Feb 16, 2021 | Brockstedt Dirk G.71 | Chief Scientific Officer | Sale+OE | 9,877 | $21.22 | $209,589.94 | -33.3% | - | - | |
| Feb 1, 2021 | Ho William75 | Chief Medical Officer | Sell | 1,000 | $19.99 | $19,990.00 | -1.5% | - | - | |
| Jan 15, 2021 | Ho William75 | Chief Medical Officer | Sell | 1,000 | $21.05 | $21,050.00 | -0.7% | - | - | |
| Jan 6, 2021 | Brockstedt Dirk G.71 | Chief Scientific Officer | Sell | 2,000 | $19.71 | $39,428.14 | -5.2% | - | - | |
| Jan 4, 2021 | Ho William75 | Chief Medical Officer | Sell | 1,000 | $19.75 | $19,750.00 | -0.7% | - | - |